Tobias Financial Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-150
| Closed | -$2.54K | – | 112 |
|
|
2024
Q3 | $2.54K | Hold |
150
| – | – | ﹤0.01% | 108 |
|
|
2024
Q2 | $4.22K | Hold |
150
| – | – | ﹤0.01% | 104 |
|
|
2024
Q1 | $45K | Hold |
150
| – | – | 0.01% | 102 |
|
|
2023
Q4 | $35.4K | Hold |
150
| – | – | 0.01% | 96 |
|
|
2023
Q3 | $22.5K | Hold |
150
| – | – | 0.01% | 89 |
|
|
2023
Q2 | $26.1K | Hold |
150
| – | – | 0.01% | 95 |
|
|
2023
Q1 | $18.9K | Buy |
+150
| New | +$18.9K | 0.01% | 83 |
|